ecteinascidin 743 has been researched along with Peritoneal Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Esser, M; Fritz, J; Horger, M; Kloth, C; Kopp, HG; Reinert, CP; Thaiss, WM | 1 |
| Adam, J; Ahlenc-Gelas, M; Cavalcanti, A; Domitrescu, G; Dumont, S; El Amarti, L; Honore, C; Kiavue, N; Klausner, G; Le Cesne, A; Mir, O; Sourrouille, I; Terrier, P; Verret, B | 1 |
| Adenis, A; Hollebecque, A; Lebedinsky, C; Penel, N; Taieb, S | 1 |
| Bonebrake, AJ; De Geest, K; Edwards, R; Hanjani, P; Monk, BJ; Rotmensch, J; Sill, MW; Walker, JL | 1 |
| Markman, M | 1 |
2 trial(s) available for ecteinascidin 743 and Peritoneal Neoplasms
| Article | Year |
|---|---|
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimens: a phase II study of the Gynecologic Oncology Group.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Docetaxel; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Taxoids; Tetrahydroisoquinolines; Trabectedin | 2011 |
Docetaxel plus trabectedin appears active in recurrent or persistent ovarian and primary peritoneal cancer after up to three prior regimes: a phase II study of the Gynecologic Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Docetaxel; Female; Humans; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms; Taxoids; Tetrahydroisoquinolines; Trabectedin | 2011 |
3 other study(ies) available for ecteinascidin 743 and Peritoneal Neoplasms
| Article | Year |
|---|---|
CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin.
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Agents, Alkylating; Female; Humans; Male; Middle Aged; Peritoneal Neoplasms; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Trabectedin | 2018 |
Trabectedin in advanced desmoplastic round cell tumors: a retrospective single-center series.
Topics: Adult; Antineoplastic Agents, Alkylating; Desmoplastic Small Round Cell Tumor; Dioxoles; Female; Humans; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Pleural Neoplasms; Retrospective Studies; Tetrahydroisoquinolines; Trabectedin; Young Adult | 2017 |
Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients.
Topics: Antineoplastic Agents, Alkylating; Clinical Trials, Phase II as Topic; Dioxoles; Humans; Leiomyosarcoma; Male; Middle Aged; Neoplasm Metastasis; Peritoneal Neoplasms; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome | 2010 |